Table 3.
Patterns of adoption and diffusion of TZD in 327 long-term hospitals
| Initial time (month) | Peak Penetration1 | Time to Peak (month) | Monthly growth (DDD/month) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | mean | std | Mean | std | mean | std | mean | std | |
| Total number | 15.19 | 11.61 | 0.1166 | 0.0667 | 26.69 | 13.42 | 252.65 | 374.31 | |
| Accreditation level | |||||||||
| Medical Center | 18 | 8.28 | 10.31 | 0.1034 | 0.0402 | 34.67 | 12.25 | 1275.25 | 692.43 |
| Regional Hospital | 68 | 10.97 | 9.52 | 0.0985 | 0.0516 | 31.68 | 11.07 | 410.71 | 298.44 |
| District Hospital | 241 | 16.90 | 11.77 | 0.1227 | 0.0711 | 24.69 | 13.57 | 131.67 | 176.87 |
| Ownership | |||||||||
| Public Hospital | 67 | 15.94 | 10.96 | 0.0782 | 0.0469 | 25.63 | 12.54 | 302.22 | 446.00 |
| Non-profit Hospital | 65 | 12.22 | 10.18 | 0.1155 | 0.0543 | 31.40 | 12.45 | 467.35 | 513.15 |
| Private Hospital | 195 | 15.93 | 12.15 | 0.1302 | 0.0712 | 25.49 | 13.74 | 164.04 | 238.14 |
| BNHI Regions | |||||||||
| Taipei | 78 | 13.12 | 9.96 | 0.1204 | 0.0657 | 28.19 | 13.10 | 314.77 | 475.98 |
| Northern | 49 | 16.82 | 12.21 | 0.0818 | 0.0465 | 23.53 | 13.52 | 274.29 | 397.45 |
| Central | 81 | 16.93 | 12.21 | 0.1333 | 0.0683 | 26.95 | 12.85 | 203.92 | 284.37 |
| Southern | 49 | 14.08 | 11.22 | 0.1164 | 0.0689 | 22.90 | 11.79 | 294.41 | 374.88 |
| Kao-Ping | 59 | 15.29 | 12.86 | 0.1189 | 0.0718 | 28.83 | 15.56 | 201.43 | 328.36 |
| Eastern | 11 | 14.36 | 8.72 | 0.1104 | 0.0566 | 33.64 | 8.16 | 163.19 | 182.91 |
1: Peak Penetration among patients receiving non-insulin anti-diabetic agents